DOI QR코드

DOI QR Code

Importance of family segregation in the American College of Medical Genetics and Genomics and Association of Molecular Pathology guidelines: Case of a Korean family with autosomal dominant polycystic disease

  • Kwon, Won Kyung (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Suhee (Outpatient Nursing Team, Samsung Medical Center) ;
  • Jang, Ja-Hyun (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kim, Jong-Won (Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2020.05.19
  • Accepted : 2020.06.17
  • Published : 2020.06.30

Abstract

Since the American College of Medical Genetics and Genomics and Association of Molecular Pathology published their guidelines in 2015, most interpretations of genetic tests have followed them. However, all variants have only limited evidence along 28 interpretation standards, especially de novo variants. When de novo variants, which are classified as variants of uncertain significance (VUS) due to lack of evidence, are detected, segregation in the affected family could provide an important key to clarifying the variants. Autosomal dominant polycystic kidney disease is the most common inherited kidney disorder with pathogenic variants in the PKD1 or PKD2 genes. We detected a novel in-frame deletion variant in the PKD1 gene, c.7575_7577del (p.(Cys2526del)), which was interpreted as a VUS. We analyzed this variant in a Korean family to decide for segregation. Here, we report the variant as a likely pathogenic variant based on the evidence of segregation in three affected relatives and two unaffected members.

Keywords

References

  1. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
  2. Simms RJ. Autosomal dominant polycystic kidney disease. BMJ 2016;352:i679. https://doi.org/10.1136/bmj.i679
  3. Wilson PD. Polycystic kidney disease. N Engl J Med 2004;350:151-64. https://doi.org/10.1056/NEJMra022161
  4. Srivastava A, Patel N. Autosomal dominant polycystic kidney disease. Am Fam Physician 2014;90:303-7.
  5. Lai S, Mastroluca D, Matino S, Panebianco V, Vitarelli A, Capotosto L, et al. Early markers of cardiovascular risk in autosomal dominant polycystic kidney disease. Kidney Blood Press Res 2017;42:1290-302. https://doi.org/10.1159/000486011
  6. Kurashige M, Hanaoka K, Imamura M, Udagawa T, Kawaguchi Y, Hasegawa T, et al. A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney disease. Clin Genet 2015;87:266-72. https://doi.org/10.1111/cge.12372
  7. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-7. https://doi.org/10.1016/S0140-6736(94)92026-5
  8. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, et al.; CRISP Investigators. Volume progression in polycystic kidney disease. N Engl J Med 2006;354:2122-30. https://doi.org/10.1056/NEJMoa054341
  9. Bayrak-Toydemir P, McDonald J, Mao R, Phansalkar A, Gedge F, Robles J, et al. Likelihood ratios to assess genetic evidence for clinical significance of uncertain variants: hereditary hemorrhagic telangiectasia as a model. Exp Mol Pathol 2008;85:45-9. https://doi.org/10.1016/j.yexmp.2008.03.006
  10. The Clinical Genome Resource Gene Curation Working Group. Gene clinical validity curation process: standard operating procedure. Version 7. [https://clinicalgenome.org/site/assets/files/3975/genedisease_validity_standard_operating_procedures_version_7_highlighted_final.pdf]
  11. Elliott AM, Friedman JM. The importance of genetic counselling in genome-wide sequencing. Nat Rev Genet 2018;19:735-6. https://doi.org/10.1038/s41576-018-0057-3